From: ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma
TWIST1 expression
Low
High
ARTN expression
Negative
14 (40%)
21 (60%)
Weak
9 (31%)
20 (69%)
Moderate
3 (20%)
12 (80%)
Strong
2 (13.3%)
13 (86.7%)